GHIT Fund Global Health Innovative Technology Fund

We seek out R&D solutions to health where others don't

We catalyze creative partnerships across different sectors and cultures

We believe medicine is invaluable with access, valueless without it

Health is a right, not an option

Scroll
Annual Report 2019
GHIT Brand Film
Strategic Plan 2018 - 2022

The Japan-based GHIT Fund is an international public-private partnership fund for global health R&D
that mobilizes Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics
for malaria, tuberculosis, and neglected tropical diseases, in collaboration with global partners.

LATEST NEWS

January 12, 2021 | News

New investment opportunity for Hit-to-Lead Platform

December 22, 2020 | Events

[Seminar 3] Webinar series on NTDs: Global Trends and Japan's Experience - Ja…

December 8, 2020 | Press Release

GHIT Fund Announces New Investments: A Total of 230 Million Yen in Drugs for …

December 3, 2020 | Events

[Seminar 2] Webinar series on NTDs: Global Trends and Japan's Experience - Ja…

November 17, 2020 | Events

[Register Now!] Webinar series on NTDs: Global Trends and Japan's Experience …

September 29, 2020 | Press Release

GHIT Fund Announces New Investments: A Total of 1.37 Billion Yen in Drugs for…
Newsroom

Why Global
Health R&D

Japan's Science and Pharmaceutical Capabilities for Global Health

Business
Model

World’s First Public-Private Partnership Fund for Global Health R&D

Investment
Opportunities

R&D Platforms and RFP Schedule

Investment to Date
since 2013

USD225M
Total Investment
97
Total Invested
Partnerships
138
Total Product
Development Partners
8
Clinical Trials

・Twitter